Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

virtualization

- PMLiVE

Don’t miss out! Get a Sneak Peek at Next-Gen Life Science Education and Training Tools

From interactive case studies to AI-driven avatars, our free webinar dives into the tools defining tomorrow’s life sciences education. Last spots available – sign up now!

Impetus Digital

- PMLiVE

Roche and Flare Therapeutics enter oncology partnership worth over $1.8bn

The companies will aim to discover small molecule treatments aimed at previously undrugged transcription factor targets

- PMLiVE

Pharma-exclusive Webinar: Next-gen Virtual Tools for Education & Learning in the Life Sciences

Unlock the potential of next-gen virtual tools in our upcoming webinar. From AI simulations to interactive AR booths, learn how to effectively apply these technologies in life sciences education and...

Impetus Digital

Adopting a Growth Mindset – Building Company Culture Virtually

Transform challenges into opportunities with our new video series on creating vibrant company culture remotely. Learn how adopting a growth mindset can enhance your leadership and foster a thriving remote...

Impetus Digital

- PMLiVE

Roche’s Alecensa receives NICE recommendation to treat ALK-positive lung cancer

Just under 100 non-small cell lung cancer patients in England will be eligible for the drug

- PMLiVE

Jazz shares positive results for Zepzelca combination in phase 3 lung cancer study

Approximately 30,000 new cases of small cell lung cancer are reported in the US every year

- PMLiVE

Roche presents two-year data for spinal muscular atrophy treatment Evrysdi in children

The severe and progressive neuromuscular disease affects about one in every 10,000 babies

- PMLiVE

Roche’s Itovebi combination granted FDA approval for advanced breast cancer

Approximately 310,720 women will be diagnosed with invasive breast cancer in the US this year

- PMLiVE

Top-10 ways for Pharma to leverage AI according to…AI

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s remarkable to see the progress made in the technology compared to...

Impetus Digital

- PMLiVE

Roche’s Genentech acquires Regor Pharmaceuticals’ CDK inhibitors for $850m upfront

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study

- PMLiVE

Roche’s injectable C5 inhibitor PiaSky recommended by NICE for rare blood disorder PNH

Paroxysmal nocturnal haemoglobinuria affects approximately 1.59 per 100,000 people in the UK

Advantages of Virtual Collaboration – Perks of Virtual Medical Education

From extended reach and enhanced interactivity to increased speed and flexibility, learn why virtual settings are becoming a staple in education and professional interaction. Embrace the future of collaboration today!

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links